Detalles de la búsqueda
1.
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
Lancet
; 397(10274): 592-604, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581821
2.
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(22): 2078-2092, 2018 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29658856
3.
Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients.
BMC Cancer
; 17(1): 251, 2017 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28390415
4.
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
Oncologist
; 21(5): 618-25, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27009937
5.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Lancet Oncol
; 16(5): 499-508, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25877855
6.
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma.
J Immunother Cancer
; 11(10)2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37848259
7.
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial.
Nat Med
; 29(11): 2814-2824, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37857711
8.
A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED).
Front Oncol
; 12: 862427, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35719960
9.
Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review.
Immunotherapy
; 14(7): 511-520, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35321560
10.
Clinical and molecular profile of young adults with early-onset colorectal cancer: Experience from four Australian tertiary centers.
Asia Pac J Clin Oncol
; 18(6): 660-668, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35098672
11.
A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.
Cancer
; 117(20): 4732-9, 2011 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21456002
12.
Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles.
Anticancer Drugs
; 22(1): 24-34, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20881836
13.
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study.
J Clin Oncol
; 39(32): 3633-3644, 2021 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34436928
14.
A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy.
Mol Cancer
; 9: 69, 2010 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20350333
15.
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
J Clin Oncol
; 38(14): 1505-1517, 2020 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32150489
16.
Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate.
Anticancer Drugs
; 20(9): 822-31, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19606016
17.
First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment.
Asia Pac J Clin Oncol
; 15(3): 151-157, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30843362
18.
Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
Clin Colorectal Cancer
; 17(3): e549-e555, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29861156
19.
nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial.
Asia Pac J Clin Oncol
; 14(5): e325-e331, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29932294
20.
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
N Engl J Med
; 350(23): 2343-51, 2004 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-15175436